Nimbha Biotech Private Limited - Due diligence report

A 360° intelligence report on Nimbha Biotech Private Limited: trust score, financial health, credit view, compliance, directors, growth and …

2000-01-20 Hyderabad, Telangana Amalgamated Unlisted Active Compliant
Share
Connect MCP
NB Nimbha Biotech Private Limited
Full Due-Diligence Report + Documents
  • Unlock all financial figures & 5-year trends
  • Full trust, health & credit-risk scores
  • Director details, charges & MCA documents
₹700 ₹449 Save ₹251 excl. GST
Or from ₹279/report with credits View credit packages
Company Credits – Starter
  • One credit unlocks this full due-diligence report
  • Use across any company’s report, anytime
  • Credits valid for 12 months
× ₹700 ₹279 = ₹2,790 60% off
Choose your own credit amount View credit packages

Nimbha Biotech Private Limited — 360° Intelligence Report

Generated from MCA filings & public records
62/100
Trust Score
Moderate

Nimbha Biotech Private Limited is assessed as Moderate with a Trust Score of 62/100. Nimbha Biotech Private Limited is a private limited indian non-government company incorporated in 2000, operating in the Agriculture sector. The company has shown revenue growth across its recent filed years. It was profitable in its latest filed year. Based on MCA filings and public records, it currently shows a high compliance risk and low financial risk profile.

Report generated on 09 Aug 2026 from the latest processed filings. Nimbha Biotech Private Limited snapshot & full profile →

Financial Health › Strong
Overall Assessment CautionWeakNeutralGoodStrong Good
Compliance › Caution

Automated indicators derived from public MCA / GST / EPFO records - not a credit rating, not investment, legal or financial advice. Spotted an inaccuracy? Report an error.

02

Score Card

Higher is safer · rule-based & explainable
Trust ScoreModerate
62/100
Overall counterparty trust - the headline number of this report.
Compliance ScoreCaution Indicated
16/100
Statutory standing - status, filings, auditor, MSME and litigation.
Financial Health ScoreLow Risk
85/100
Profitability, leverage and liquidity from filed statements.
Credit Risk ScoreModerate
55/100
Debt capacity, gearing and security cover for lenders.
Director Stability ScoreLow Risk
95/100
Board strength, DIN status, churn and network.
Growth ScoreLow Risk
95/100
Revenue, profit, asset and hiring momentum.
Distress ScoreModerate
55/100
Early-warning signals - higher means fewer warnings.
03

Financial Intelligence Dashboard

Standalone · 5 filed year(s)

Unlock the full 5-year financial dashboard with charts and year-wise figures.

Get full access

Scores and observations on this page are already computed from the real filings - only the underlying figures are locked.

04

Credit & Compliance Intelligence

Why the scores are what they are
Credit Risk Score: 55/100 Moderate
  • Negative operating earnings - debt service depends on external support.
  • No open charges - unencumbered balance sheet.
  • Profitable - internal accruals available.

Charges position: 0 open (-) · 0 satisfied (-).

Compliance Score: 16/100 Caution Indicated
  • Company status is "Amalgamated" - not Active.
  • Last balance sheet is for Mar 2022 - filings overdue.
  • Litigation present in 2 court forum(s).
Legal cases on record (2)
05

Director Intelligence

Stability score: 95/100
NameDIN / PANDesignationAppointedTenureDIN status
SRINIVASARAJU CHINTALAPATI 01234567 Director 01/04/2018 6 yrs Approved
JYOTHI RAJU CHINTALAPATI 01234567 Director 01/04/2018 6 yrs Approved
  • 2 directors on the board.
  • No disqualified or deactivated DINs.
  • Stable board - no exits in 3 years.
  • Average tenure above 5 years.
06

Ownership & Group Intelligence

As per FY 2022 annual return
Promoter holding
64.27%
Public / other holding
35.73%
Equity shares
12,45,67,890
Equity paid-up
124.5 cr
Promoters on record
4
Ultimate holding entity
-
Subsidiaries
-
Group entities
-
Capital events
1 allotment(s) · 1 transfer(s)

Promoters hold a dominant controlling stake - exact percentages are part of the full report.

Group entityRelationship% held
Capitalone Infrastructure India Private Limited Associate Company 74.00%

Full shareholding pattern, group structure & capital events →

07

Risk Intelligence Center

Growth 95 · Distress 55
Growth signals & trust indicators
Revenue acceleration: +38% over 4 year(s).
Latest year revenue grew 1.42.
Profit expanded 2.1x year-on-year.
Asset base grew 24% - capacity expansion.
Operating for 26+ years.
Distress signals & risk flags
Statutory filings appear overdue.
Adverse company status: Amalgamated.
Compliance score is weak (16/100).
2 court case(s) on record - see the legal section for details.
08

Stakeholder Verdicts

Vendor · Banker · Investor
Vendor due diligence42/100
Caution indicated
Suitability as a supplier / customer counterparty.
  • Check the compliance flags before onboarding.
  • 2 distress signal(s) - see Risk Center.
  • Financial filings available for verification.
Banker assessment54/100
Mixed indicators - deeper appraisal suggested
Indicative lending comfort for banks, NBFCs and trade credit.
  • Debt capacity assessed from filed statements.
  • No existing security registered - first-charge position available.
  • Compliance gaps should be priced into terms.
Investor view83/100
Positive growth indicators
Growth quality and scalability through an investor lens.
  • 4 growth signal(s) detected.
  • Margin and return trends computable from filings.
  • Management team looks stable.
09

MCA Filings & Events Timeline

Latest 11 events
31 Dec 2022
Last AGM held
Annual general meeting
31 Mar 2022
Latest balance sheet
Filed with ROC
22 Sep 2018
Director ceased
SRINIVASARAJU CHINTALAPATI
19 Jan 2018
Director appointed
SRINIVASARAJU CHINTALAPATI (Director)
Director ceased
RAMESH BABU GOPIGIRI
25 Sep 2017
Director ceased
JYOTHI RAJU CHINTALAPATI
31 Mar 2017
Share transfer (FY 2017)
2849500.00000000 shares to CAPITAL HOLDINGS LLP
29 Sep 2016
Director appointed
JYOTHI RAJU CHINTALAPATI (Director)
08 Sep 2016
Director ceased
SUBBA RAO SIKHAKOLLI
23 Mar 2015
Securities allotted
2840000 Equity Shares Without Differential Rights - 2.84 cr raised
20 Jan 2000
Incorporated
Registered with Roc Hyderabad
10

Key Observations

Auto-generated from the data above
Revenue grew 0.86 over the last 4 financial year(s).
Net worth is positive.
2 active director(s) / partner(s); board looks stable and experienced.
Promoters hold a dominant controlling stake as per the FY 2022 annual return.
Capital has been raised through 1 security allotment(s) - amounts available in the full report.
2 overseas direct investment(s) (ODI) on record - international footprint.
11

Peers & Related Companies

Full peer comparison →
CompanyCINLocation
N Desai Papers Pvt Ltd U21019GJ1995PTC024951 Ahmedabad, Gujarat, India
J.J Shah Papers Private Limited U21093MH2007PTC175339 Mumbai, Maharashtra, India
Jai Durga Multi-Trade Private Limited U51102CT2009PTC021385 Ambikapur, Chattisgarh, India
T M Yogesh Textile Private Limited U51311OR2003PTC007096 Cuttack, Orissa, India
Gee Ess Emm Jewellers Private Limited U52599TN1994PTC027219 Chennai, Tamil Nadu, India
Abhilasha Commercial Pvt.Ltd.. U51909UP1993PTC040781 Noida, Uttar Pradesh, India
Suarabhakti Goods Private Limited U51909MH2004PTC331820 Mumbai, Maharashtra, India
Spl Steel Processors Private Limited U27200WB2018PTC229009 Saltlake, West Bengal, India
12

Who Uses This Report

CA · CS · Banker · Investor · Vendor
Chartered Accountants (CA)

Verify Nimbha Biotech Private Limited before audits and certifications: compliance score 16/100, filing history, auditor history and charge records in one place - instead of pulling each MCA form separately.

Company Secretaries (CS)

Track statutory health of Nimbha Biotech Private Limited: ACTIVE compliance status, annual-return recency, director DIN status, board churn and the events timeline - the inputs for secretarial audits and due-diligence certificates.

Bankers & NBFCs

Current banker verdict: Mixed indicators - deeper appraisal suggested. Credit risk score 55/100, existing charge position and lender relationships - a first-pass credit memo before formal appraisal.

Investors & Analysts

Investor view: Positive growth indicators. Growth score 95/100, margin trends, ownership structure and peer set for Nimbha Biotech Private Limited - screening before a deeper diligence.

Vendors & Procurement Teams

Vendor verdict: Caution indicated. Trust score 62/100, distress signals and MSME payment-delay disclosures - know whether Nimbha Biotech Private Limited pays its suppliers before you extend credit terms.

Lawyers & Compliance Teams

Litigation footprint (2 case(s) on record), regulatory flags, charge documents trail and director networks for Nimbha Biotech Private Limited - groundwork for KYC, onboarding and disputes.

13

Frequently Asked Questions

Is Nimbha Biotech Private Limited an active company?

Nimbha Biotech Private Limited has MCA status “Amalgamated” with a compliance score of 16/100 (Caution Indicated).

Is Nimbha Biotech Private Limited financially healthy?

Nimbha Biotech Private Limited has a Financial Health Score of 85/100 (Low Risk) based on its filed financial statements.

Should I do business with Nimbha Biotech Private Limited?

Its overall Trust Score is 62/100 (Moderate). Vendor verdict: Caution indicated. Review the risk flags in the Risk Intelligence Center before deciding.

Who controls Nimbha Biotech Private Limited?

Promoters hold a dominant controlling stake - exact percentages are in the full report. 2 active director(s) are on record.

Does Nimbha Biotech Private Limited have loans or charges against its assets?

No charges are registered against this company - an unencumbered balance sheet.

Is Nimbha Biotech Private Limited up to date with its ROC filings?

Last balance sheet is for Mar 2022 - filings overdue. Overall compliance score: 16/100 (Caution Indicated).

Is it risky to lend to Nimbha Biotech Private Limited?

Its Credit Risk Score is 55/100 (Moderate). Banker verdict: Mixed indicators - deeper appraisal suggested.

Disclaimer: This report is generated automatically from MCA filings and public records as available in our system at the time of the last update. Scores, bands and verdicts are rule-based derived indicators of the underlying data - they are opinions generated by an algorithm, not statements of fact about the company, and are not credit ratings (within the meaning of SEBI regulations), audits, or investment, legal or financial advice. Verify from official sources and consult a qualified professional before any business, lending or investment decision. If you represent this company and believe any information is inaccurate or outdated, report it here and we will review promptly.